{"id":1098913,"date":"2026-10-04T02:28:36","date_gmt":"2026-10-04T02:28:36","guid":{"rendered":"https:\/\/www.europesays.com\/us\/1098913\/"},"modified":"2026-10-04T02:28:36","modified_gmt":"2026-10-04T02:28:36","slug":"easd26-lillys-amylin-zepbound-combo-posts-best-ever-weight-loss-in-patients-with-obesity-and-diabetes-endpoints-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/1098913\/","title":{"rendered":"#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes &#8211; Endpoints News"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxNSFB0dlM2UDRfMzBjamdldzJScHlCZTRfcTdlaWd4ckRMTzR2Mm1oeWpCRUxyTFNwRVlsLXVRNVJkRmtzWU9qUXF4MG1HT01aekFqOE1pcS1IOTVQQUt4dU5YQ3BZTTcyQmR0cU40RnY1LUg5T2UwVXRZekhneHhZS1drbGNzckRIVVRQWlBTaXJYTTctRHJNM0tuSVdQNTNwZmh6b0RtQjM2dHBXV2Rxam9HcVFtQUkybEoyY19RdDRKdzQ?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes<\/a>&nbsp;&nbsp;Endpoints News<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMid0FVX3lxTE9nLU5qVURCR0h4SmxQUjdDYXdPYUtUa3VzUzdGM3d1MWlEY1JldnpuekktRkFUOHVBbTZtM3BEQWVrNmg3U1J0TVdUSmp5Zmg0ZXZLSWZXTm1udlBxak9QaDMxV2h1QlJybXVnS3NJYjJUdHNBZnlv0gF8QVVfeXFMTWVtbmp4Rmx2aWF1ZFVheklrLVhPdV9KYUlNUTR1NDM0U3kyQndmcVQyWnV5VTdEU29aRmgtMFpJbWc4RUZSWmlOZV9kb3d4M3I1Z01CdVNSQkx0ZHJpekEySUR5OTA3V2pjZzJrVFN4Ql9IVkoyNFhmMHlSSA?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s<\/a>&nbsp;&nbsp;CNBC<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxOb25xR3djUTZrOHZrOWc3em9vZ0IxRU51R1I5M2xoVUZBdXlYVnZCOEEtOUpNUnBSOWdiWnRyTzJlT1ZBV0JqRkl1cUtPZjBzclhISEhrZ25SRFlVVTQyVzNMRnVfYzNqeHVMWjloU1o0NzZNTTJ4T2tqaVIxVlpRU3R1Vkt1c3VYcl9GRWVOODIzaHM0bUdNYkVGcXpfSHBaWnd0blRxb2FMYUc2Vi01Qnk5dXVZREZkMnZDTFNpSEVtdlE?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Blockbuster retatrutide trial signals a \u2018new high-water mark\u2019 for weight-loss drugs<\/a>&nbsp;&nbsp;Scientific American<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMivAFBVV95cUxPd091UFNjZjRoTng5cVJCUXRNblZ0ZnBOR2xtUlhXN3lEQUtkUGtGZTBRdk11SnhCT1N0WTVFYVIwNmZMeUd6RzZiSmNxMHVWdHlORDhIWDdnVjJVc2lMTTQwdERSZVYwTG5JUlpwQWxna1JDRl9fWHZIdTh3QUhYaEdITW5lczgyVnp1aTZDcVdkdVRKeGZjeTNGU1luRUJGQUYwMUwyckdVdFdIOGhYOVNYV0VTd1ZiZVlhTg?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">Experimental Lilly combination drug tops Zepbound in weight-loss trial<\/a>&nbsp;&nbsp;Reuters<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMisAFBVV95cUxNZjU0dVc4YkpBc242NkRGT00xZVZLR0dRaUlweTQyY2dFa3NVaVVldk44U1JFcjVwYzFqWFp4NVg5eWxZbGM3OVdSNE9qWTNCaFNNZEFQUzc1RzhuWUJsZnlTbmFiSVYtVzdWdll3OW42d3ZVaURJQnc3Z2pZR2pmOXhHNWdtWFB2b1pVc05KMTFveWRjUFhOajExQkRfcWw4UWJ4cnRfOWNmbzZvMVVjZw?oc=5\" target=\"_blank\" rel=\"nofollow noopener\">\u2018Godzilla\u2019 of weight-loss drugs could provide other important health benefits<\/a>&nbsp;&nbsp;The Guardian<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"#EASD26: Lilly\u2019s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes&nbsp;&nbsp;Endpoints News Why Lilly and&hellip;\n","protected":false},"author":3,"featured_media":1098914,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[439332,439333,439334,210,126182,1060,10943,60244,205372,172067,24040,67,132,68,428,15208],"class_list":["post-1098913","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-cagrisema","tag-eloralintide","tag-eloratzp","tag-health","tag-lilly","tag-medication","tag-obesity","tag-rd","tag-retatrutide","tag-tirzepatide","tag-type-2-diabetes","tag-united-states","tag-unitedstates","tag-us","tag-weight-loss","tag-zepbound"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117380284577016347","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1098913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=1098913"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/1098913\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/1098914"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=1098913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=1098913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=1098913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}